CytoSorbents Corp (CTSO)
0.8217
-0.06
(-6.52%)
USD |
NASDAQ |
Apr 24, 16:00
0.8225
0.00 (0.00%)
After-Hours: 20:00
CytoSorbents Revenue (Quarterly): 7.348M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.348M |
| September 30, 2023 | 7.754M |
| June 30, 2023 | 8.072M |
| March 31, 2023 | 7.91M |
| December 31, 2022 | 7.642M |
| September 30, 2022 | 6.463M |
| June 30, 2022 | 7.331M |
| March 31, 2022 | 7.924M |
| December 31, 2021 | 9.698M |
| September 30, 2021 | 8.902M |
| June 30, 2021 | 11.37M |
| March 31, 2021 | 10.14M |
| December 31, 2020 | 11.53M |
| September 30, 2020 | 10.25M |
| June 30, 2020 | 9.520M |
| March 31, 2020 | 8.156M |
| December 31, 2019 | 6.610M |
| September 30, 2019 | 5.728M |
| June 30, 2019 | 5.850M |
| March 31, 2019 | 4.577M |
| December 31, 2018 | 5.471M |
| September 30, 2018 | 5.103M |
| June 30, 2018 | 5.246M |
| March 31, 2018 | 4.433M |
| December 31, 2017 | 4.296M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.449M |
| June 30, 2017 | 3.041M |
| March 31, 2017 | 2.596M |
| December 31, 2016 | 2.613M |
| September 30, 2016 | 2.143M |
| June 30, 2016 | 1.853M |
| March 31, 2016 | 1.597M |
| December 31, 2015 | 1.496M |
| September 30, 2015 | 1.072M |
| June 30, 2015 | 0.7843M |
| March 31, 2015 | 0.7045M |
| December 31, 2014 | 0.8737M |
| September 30, 2014 | 1.034M |
| June 30, 2014 | 0.6657M |
| March 31, 2014 | 0.5709M |
| December 31, 2013 | 0.3142M |
| September 30, 2013 | 0.2036M |
| June 30, 2013 | 0.128M |
| March 31, 2013 | 0.1761M |
| December 31, 2012 | 0.088M |
| September 30, 2012 | 0.0137M |
| June 30, 2012 | 0.033M |
| March 31, 2012 | 0.0169M |
| December 31, 2011 | 0.0361M |
| September 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
5.728M
Minimum
Sep 2019
11.53M
Maximum
Dec 2020
8.326M
Average
7.924M
Median
Mar 2022
Revenue (Quarterly) Benchmarks
| Delcath Systems Inc | 0.539M |
| Star Equity Holdings Inc | 14.11M |
| Exact Sciences Corp | 646.88M |
| Illumina Inc | 1.122B |
| Progyny Inc | 269.94M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.835M |
| Total Expenses (Quarterly) | 16.69M |
| EPS Diluted (Quarterly) | -0.12 |
| Enterprise Value | 35.52M |
| Gross Profit Margin (Quarterly) | 54.32% |
| Profit Margin (Quarterly) | -79.40% |
| Earnings Yield | -77.89% |
| Normalized Earnings Yield | -82.07 |